PTC Therapeutics Inc
F:BH3
PTC Therapeutics Inc
F:BH3
Price:
60.54
EUR
2.85%
Market Cap:
€4.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
PTC Therapeutics Inc
F:BH3
|
US |
|
Ralph Lauren Corp
NYSE:RL
|
US |
|
S
|
Southern Co
DUS:SOT
|
US |
|
JCDecaux SE
OTC:JCDXY
|
FR |
|
Avi Ltd
F:IZ6
|
ZA |
|
E
|
Eldorado Gold Corp
F:ELO1
|
CA |
|
M
|
MERLIN Properties SOCIMI SA
ELI:MRL
|
ES |
|
B
|
Barrick Gold Corp
DUS:ABR
|
CA |
|
A
|
Autodesk Inc
XMUN:AUD
|
US |
|
A
|
Accenture PLC
F:CSA
|
IE |
|
E
|
Encompass Health Corp
F:HSOA
|
US |
Wall St Price Targets
BH3 Price Targets Summary
PTC Therapeutics Inc
PTC Therapeutics Inc
Wall Street analysts forecast BH3 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for BH3 is 84.11 EUR with a low forecast of 59.25 EUR and a high forecast of 114.4 EUR.
Lowest Forecast
Price Target
59.25
EUR
2% Downside
Average Forecast
Price Target
84.11
EUR
39% Upside
Highest Forecast
Price Target
114.4
EUR
89% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BH3's stock price target?
Price Target
84.11
EUR
84.11
EUR
According to Wall Street analysts, the average 1-year price target for BH3 is 84.11 EUR with a low forecast of 59.25 EUR and a high forecast of 114.4 EUR.
